08HH.F SHANG.FOS.PHARM.GR.H YC 1

Healthcare Pharmaceuticals Frankfurt Exchange
9.12 EUR
Close of Nov 11, 2026
1.61 2.44
Market cap
EUR 5.04B
P/E
11.1x
P/B
0.78x
ROE
7.1%
Dividend yield
2.61%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 08HH.F undervalued?

Graham number
Price9.12
Graham value14.75
Discount38.1%

08HH.F trades 38.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SHANG.FOS.PHARM.GR.H YC 1 fundamental analysis

No fundamental analysis for SHANG.FOS.PHARM.GR.H YC 1 yet.

SHANG.FOS.PHARM.GR.H YC 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SHANG.FOS.PHARM.GR.H YC 1

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabo…

Full company profile